Hisami Yamanaka-Okumura

Dr. Hisami Yamanaka-Okumura

Tokushima University
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2015 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
YKYuka Kawakami
Yuka Kawakami
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
YNYuko Naniwa-Kuroki
Yuko Naniwa-Kuroki
MSMasae Sakuma
Masae Sakuma
YTYutaka Taketani
Yutaka Taketani
ETEiji Takeda
Eiji Takeda
The effects of alpha-linolenic acid (ALA) on cardiovascular risk factors considerably vary between published reports. Therefore, we investigated the effects of 12-week supplementation with flaxseed oil (FO), which is a rich source of ALA, on cardiovascular risk factors such as serum small dense low-density lipoprotein (sd-LDL) concentrations. In a randomized, double blind, crossover study, 15 subjects ingested 10 g of FO or corn oil (CO), containing 5.49 g and 0.09 g of ALA, respectively, once daily with dinner. Blood samples were collected at 0, 4 and 12 weeks, and were used for analysis of serum lipid, lipid-related proteins, serum fatty acids and serum sd-LDL cholesterol. Differences during the test period were identified using a repeated-measures analysis of variance (ANOVA) for within-group effects. Group differences were identified using paired t-test at each blood sampling time point. ALA and eicosapentaenoic acid concentrations were significantly higher in the FO period at 4 and 12 weeks than in the CO period. No significant differences in docosahexaenoic acid concentrations were observed between two periods, and cholesteryl ester transfer protein and apolipoprotein B concentrations were significantly lower in the FO period than in the CO period at 12 weeks. FO supplementation was associated with a significant decrease in sd-LDL concentrations at 4 and 12 weeks, and CO supplementation had no effect. Moreover, sd-LDL concentrations were significantly lower in the FO period than in the CO period at 4 weeks. Among subjects with triglyceride (TG) concentrations of >100 mg/dl, FO supplementation markedly reduced sd-LDL concentrations at 4 and 12 weeks compared with baseline. Sd-LDL concentrations significantly differed between the periods at both 4 and 12 weeks. This study indicates that the FO, which is a rich source of ALA, leads to lower sd-LDL cholesterol concentrations.

1 November 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
HOHitoshi Ozawa
Hitoshi Ozawa
Akiyoshi HirayamaAkiyoshi Hirayama
Akiyoshi Hirayama
FSFutaba Shoji
Futaba Shoji
MMMidori Maruyama
Midori Maruyama
KSKumi Suzuki
Kumi Suzuki
MTMasaru Tomita
Masaru Tomita
As the physical properties and functionality of dipeptides differ from those of amino acids, they have attracted attention in metabolomics; however, their functions in vivo have not been clarified in detail. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and its major cause is chronic hepatitis. This study was conducted to explore tumor-specific dipeptide characteristics by performing comprehensive dipeptide analysis in the tumor and surrounding nontumor tissue of patients with HCC. Dipeptides were analyzed by liquid chromatography tandem mass spectrometry and capillary electrophoresis tandem mass spectrometry. Principal component analysis using 236 detected dipeptides showed differences in the dipeptide profiles between nontumor and tumor tissues; however, no clear difference was observed in etiological comparison. In addition, the N- and C-terminal amino acid compositions of the detected dipeptides significantly differed, suggesting the substrate specificity of enzyme proteins, such as peptidase. Furthermore, hepatitis-derived HCC may show a characteristic dipeptide profile even before tumor formation. These results provide insight into HCC pathogenesis and may help identify novel biomarkers for diagnosis.

1 April 2019 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
HMHiroki Maki
Hiroki Maki
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
TKTakafumi Katayama
Takafumi Katayama
YOYuka Ozawa
Yuka Ozawa
AHAkihito Hosoda
Akihito Hosoda
FAFumitake Amemiya
Fumitake Amemiya

27 November 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
KOKohta Ohnishi
Kohta Ohnishi
SYSatoshi Yano
Satoshi Yano
MFMoe Fujimoto
Moe Fujimoto
MSMaiko Sakai
Maiko Sakai
EHErika Harumoto
Erika Harumoto
YTYutaka Taketani
Yutaka Taketani
Autophagy is a major degradation system for intracellular macromolecules. Its decline with age or obesity is related to the onset and development of various intractable diseases. Although dietary phytochemicals are expected to enhance autophagy for preventive medicine, few studies have addressed their effects on the autophagy flux, which is the focus of the current study. Herein, 67 dietary phytochemicals were screened using a green fluorescent protein (GFP)-microtubule-associated protein light chain 3 (LC3)-red fluorescent protein (RFP)-LC3ΔG probe for the quantitative assessment of autophagic degradation. Among them, isorhamnetin, chrysoeriol, 2,2′,4′-trihydroxychalcone, and zerumbone enhanced the autophagy flux in HeLa cells. Meanwhile, analysis of the structure–activity relationships indicated that the 3′-methoxy-4′-hydroxy group on the B-ring in the flavone skeleton and an ortho-phenolic group on the chalcone B-ring were crucial for phytochemicals activities. These active compounds were also effective in colon carcinoma Caco-2 cells, and some of them increased the expression of p62 protein, a typical substrate of autophagic proteolysis, indicating that phytochemicals impact p62 levels in autophagy-dependent and/or -independent manners. In addition, these compounds were characterized by distinct modes of action. While isorhamnetin and chrysoeriol enhanced autophagy in an mTOR signaling-dependent manner, the actions of 2,2′,4′-trihydroxychalcone and zerumbone were independent of mTOR signaling. Hence, these dietary phytochemicals may prove effective as potential preventive or therapeutic strategies for lifestyle-related diseases.

16 June 2023 in Human Nutrition & Metabolism
Verified
Journal Article
Open access
ATAyari Tsumura
Ayari Tsumura
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
HKHana Kawakami
Hana Kawakami
SYShiori Yamamoto
Shiori Yamamoto
MOMayu Oura
Mayu Oura
YTYutaka Taketani
Yutaka Taketani

1 January 2016
Verified
Journal Article
Closed access
CAChisaki Adachi
Chisaki Adachi
HYHisami Yamanaka-Okumura
Hisami Yamanaka-Okumura
TKTakafumi Katayama
Takafumi Katayama
YTYutaka Taketani
Yutaka Taketani
ETEiji Takeda
Eiji Takeda